Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
Posted on: Thursday, 5 November 2009, 08:49 CST
OMAHA, Neb., Nov. 5 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) announces the following Webcast:
What: Transgenomic, Inc. Third Quarter 2009 Earnings Release Conference Call When: Thursday, November 5, 2009 @ 5:00 p.m. Eastern Where: http://www.transgenomic.com/events.asp?id=6 How: Live over the Internet -- Simply log on to the web at the address above. Contact: Investor Relations, 402-452-5400To access the call via telephone, call 800-862-9098 or 785-424-1051. A replay of the call will be available via telephone until 11:59 pm ET on Thursday, November 19, 2009. To access, dial 800-839-3613 or 402-220-2973.
About Transgenomic, Inc.
Transgenomic, Inc. (OTC BB: TBIO.OB, www.transgenomic.com ) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Its product offerings include the WAVE® Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, over 1,450 systems have been shipped to customers in more than 30 countries. The SURVEYOR®( )Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for high sensitivity detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared to manual methods for cytogenetic analyses. Service offerings include the Transgenomic Molecular Laboratory, which provides reference laboratory services specializing in molecular diagnostics including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology and Inherited Diseases. Transgenomic Pharmacogenomic Services is a CRO for pharmacogenomic, translational research and clinical trials.
SOURCE Transgenomic, Inc.
Source: PR Newswire
Related Articles
- US Air Force Research Laboratory (AFRL) Joins inno360 Alpha Program for Next-Generation Open Innovation
- Molecular Detection Inc. Completes $3.3 Million Financing and Names Todd M. Wallach CEO
- Phylogeny, Inc. Announces Its New microRNA in Situ Hybridization Detection Service
- Yahoo! and Computational Research Laboratories to Collaborate on Cloud Computing Research
- LabCorp to Use Affymetrix Technology for Molecular Cytogenetic Service Offering
- Dr. Luciano Rossetti, Internationally-Recognized Physician and Researcher, Joins Merck Research Laboratories in Key Leadership Role; Will Focus on Developing New Treatments for Diabetes and Obesity, Two Growing Global Health Problems
- N-Gene Research Laboratories, Inc. Reports Positive Phase II Results With BGP-15 Insulin Sensitizer
- Dr. Alan Ezekowitz, Internationally-Recognized Physician and Researcher, Joins Merck Research Laboratories in Key Leadership Role
- Aquarius Undersea Research Laboratory Wins InfoWorld 100 Award for Innovative Use of Orthogon's Wireless Solutions; Orthogon Systems & Aquarius Also Profiled As a Top 20 Implementation for 2005
- Naval Research Laboratory First to Install 128-Processor Single System Image Altix 3000 Supercomputer
 |
 |
User Comments (0)
RSS Feeds